首页> 外文期刊>Journal of Labelled Compounds and Radiopharmaceuticals >Synthesis and initial preclinical evaluation of the P2X(7) receptor antagonist [C-11]A-740003 as a novel tracer of neuroinflammation
【24h】

Synthesis and initial preclinical evaluation of the P2X(7) receptor antagonist [C-11]A-740003 as a novel tracer of neuroinflammation

机译:P2X(7)受体拮抗剂[C-11] A-740003作为神经炎症的新型示踪剂的合成与临床前评价

获取原文
获取原文并翻译 | 示例
           

摘要

Neuroinflammation, in particular activation of microglia, is thought to play an important role in the progression of neurodegenerative diseases. In activated microglia, the purinergic P2X(7) receptor is upregulated. A-740003, a highly affine and selective P2X(7) receptor antagonist, is a promising candidate for the development of a radiotracer for imaging of neuroinflammation by positron emission tomography. For this purpose, [C-11] A-740003 was synthesised and evaluated in vivo with respect to both tracer metabolism and biodistribution. In plasma, a moderate metabolic rate was seen. In healthy rat brain, only marginal uptake of [C-11] A-740003 was observed and, therefore, metabolites in brain could not be determined. Whether the minimal brain uptake is due to the low expression levels of the P2X(7) receptor in healthy brain or to limited transport across the blood-brain barrier has yet to be elucidated.
机译:神经炎症,特别是小胶质细胞的激活,被认为在神经退行性疾病的进展中起重要作用。在激活的小胶质细胞,嘌呤能P2X(7)受体被上调。 A-740003是一种高度仿射和选择性的P2X(7)受体拮抗剂,是用于开发正电子发射断层成像对神经炎症成像的放射性示踪剂的有前途的候选者。为此,合成了[C-11] A-740003,并在体内对其示踪剂代谢和生物分布进行了评估。在血浆中,观察到中等的代谢率。在健康的大鼠大脑中,仅观察到[C-11] A-740003的少量摄入,因此无法确定大脑中的代谢产物。到底是大脑吸收的最小量是由于健康大脑中P2X(7)受体的低表达水平还是由于穿过血脑屏障的有限运输所致。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号